Recently published research shows the ability of SANUWAVE Health's Extracorporeal Shock Wave Technology to stimulate proliferation of periosteal adult stem cells within the body and subsequently form bone.
A team of researchers was led by Myron Spector, MD, a professor and researcher at Harvard-MIT Division of Health Sciences and Technology. In the first phase of this research, the authors successfully demonstrated that ESWT increased the thickness of the cambium layer surrounding bone and the number of cambium cells within that layer. This proliferation of adult stem cells is an important part of many tissue engineering strategies.
In a novel second phase, the authors combined the ESWT-proliferated adult stem cells with a porous calcium phosphate scaffold that is commonly utilized in clinical applications to stimulate bone regeneration. A comparator control group received the scaffold alone with no prior ESWT treatment. The results were statistically significant and favored the ESWT group. In fact, at two weeks post-surgery, there was a significant increase in all key outcome variables for bone growth favoring the group that received ESWT prior to combination with a scaffold compared with the group that received only the scaffold.
A team of researchers was led by Myron Spector, MD, a professor and researcher at Harvard-MIT Division of Health Sciences and Technology. In the first phase of this research, the authors successfully demonstrated that ESWT increased the thickness of the cambium layer surrounding bone and the number of cambium cells within that layer. This proliferation of adult stem cells is an important part of many tissue engineering strategies.
In a novel second phase, the authors combined the ESWT-proliferated adult stem cells with a porous calcium phosphate scaffold that is commonly utilized in clinical applications to stimulate bone regeneration. A comparator control group received the scaffold alone with no prior ESWT treatment. The results were statistically significant and favored the ESWT group. In fact, at two weeks post-surgery, there was a significant increase in all key outcome variables for bone growth favoring the group that received ESWT prior to combination with a scaffold compared with the group that received only the scaffold.
Related Articles on Orthopedic Devices:
Smith & Nephew Voluntarily Withdraws Hip System Component
Maine Plans Statewide Medical Image Archive Pilot
Amedica Names Brian McEntire Chief Technology Officer